These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12234871)

  • 1. Effects of the Des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats.
    Kappel EM; Shakibaei M; Bello A; Stahlmann R
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3320-2. PubMed ID: 12234871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
    Kastner M; Rahm U; Baumann-Wilschke I; Bello A; Stahlmann R
    Arch Toxicol; 2004 Feb; 78(2):61-7. PubMed ID: 14661070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs.
    Nagai A; Miyazaki M; Morita T; Furubo S; Kizawa K; Fukumoto H; Sanzen T; Hayakawa H; Kawamura Y
    J Toxicol Sci; 2002 Aug; 27(3):219-28. PubMed ID: 12238145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy.
    Stahlmann R; Förster C; Shakibaei M; Vormann J; Günther T; Merker HJ
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2013-8. PubMed ID: 8540708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS-284756) and two fluoroquinolones in Achilles tendon from immature rats.
    Shakibaei M; Stahlmann R
    Arch Toxicol; 2003 Sep; 77(9):521-6. PubMed ID: 12811465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics.
    Förster C; Schwabe R; Lozo E; Zippel U; Vormann J; Günther T; Merker HJ; Stahlmann R
    Arch Toxicol; 1997; 72(1):26-32. PubMed ID: 9458187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of ofloxacin and magnesium deficiency on joint cartilage in immature rats.
    Lozo E; Riecke K; Schwabe R; Vormann J; Stahlmann R
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1755-9. PubMed ID: 12019086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondrotoxicity of ciprofloxacin in immature beagle dogs: immunohistochemistry, electron microscopy and drug plasma concentrations.
    Stahlmann R; Kühner S; Shakibaei M; Schwabe R; Flores J; Evander SA; van Sickle DC
    Arch Toxicol; 2000 Jan; 73(10-11):564-72. PubMed ID: 10663388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats.
    Pfister K; Mazur D; Vormann J; Stahlmann R
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1022-7. PubMed ID: 17210779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative arthropathy of fluoroquinolones in dogs.
    Takizawa T; Hashimoto K; Minami T; Yamashita S; Owen K
    Hum Exp Toxicol; 1999 Jun; 18(6):392-9. PubMed ID: 10413244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.
    Stahlmann R; Zippel U; Förster C; Schwabe R; Shakibaei M; Merker HJ; Borner K
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1470-5. PubMed ID: 9624496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolone-induced cartilage lesions are not reversible in rats.
    Förster C; Kociok K; Shakibaei M; Merker HJ; Stahlmann R
    Arch Toxicol; 1996; 70(8):474-81. PubMed ID: 8783810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondrotoxicity and toxicokinetics of novel quinolone antibacterial agents DC-159a and DX-619 in juvenile rats.
    Goto K; Yabe K; Suzuki T; Jindo T; Sanbuissho A
    Toxicology; 2010 Oct; 276(2):122-7. PubMed ID: 20688128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Ryan BM; Mazzucco CE; Lawrence LE; Ho H; Warr G; Barrett JF; Frosco M
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):27-34. PubMed ID: 11913498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients.
    Rolston KV; Frisbee-Hume S; LeBlanc BM; Streeter H; Ho DH
    Diagn Microbiol Infect Dis; 2002 Oct; 44(2):187-94. PubMed ID: 12458127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrins on joint cartilage chondrocytes and alterations by ofloxacin or magnesium deficiency in immature rats.
    Förster C; Kociok K; Shakibaei M; Merker HJ; Vormann J; Günther T; Stahlmann R
    Arch Toxicol; 1996; 70(5):261-70. PubMed ID: 8852696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lesions induced by intra-articular injections of quinolones and compounds damaging cartilage components in rat femoral condyles.
    Takada S; Kato M; Takayama S
    J Toxicol Environ Health; 1994 May; 42(1):73-88. PubMed ID: 7513367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
    Linseman DA; Hampton LA; Branstetter DG
    Fundam Appl Toxicol; 1995 Nov; 28(1):59-64. PubMed ID: 8566484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation of garenoxacin, a novel des-F(6)-quinolone antimicrobial agent: effects on the central nervous system.
    Nakamura T; Fukuda H; Morita Y; Soumi K; Kawamura Y
    J Toxicol Sci; 2003 Feb; 28(1):35-45. PubMed ID: 12696183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic disposition and arthropathic potential of oral ofloxacin in dogs.
    Yoshida K; Yabe K; Nishida S; Yamamoto N; Ohshima C; Sekiguchi M; Yamada K; Furuhama K
    J Vet Pharmacol Ther; 1998 Apr; 21(2):128-32. PubMed ID: 9597650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.